1521 related articles for article (PubMed ID: 9234575)
1. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of fungal infections in children and adolescents with cancer].
Groll AH; Ritter J; Müller FM
Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
[TBL] [Abstract][Full Text] [Related]
3. Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases.
Martino R; Nomdedéu J; Altés A; Sureda A; Brunet S; Martínez C; Domingo-Albós A
Bone Marrow Transplant; 1994 Mar; 13(3):265-9. PubMed ID: 8199569
[TBL] [Abstract][Full Text] [Related]
4. Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors.
Subirà M; Martino R; Franquet T; Puzo C; Altés A; Sureda A; Brunet S; Sierra J
Haematologica; 2002 May; 87(5):528-34. PubMed ID: 12010668
[TBL] [Abstract][Full Text] [Related]
5. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
Glasmacher A; Prentice AG
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
[TBL] [Abstract][Full Text] [Related]
7. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
[TBL] [Abstract][Full Text] [Related]
9. Invasive pulmonary aspergillosis prior to BMT in acute leukemia patients does not predict a poor outcome.
Richard C; Romón I; Baro J; Insunza A; Loyola I; Zurbano F; Tapia M; Iriondo A; Conde E; Zubizarreta A
Bone Marrow Transplant; 1993 Sep; 12(3):237-41. PubMed ID: 8241983
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies.
Mehta J; Kelsey S; Chu P; Powles R; Hazel D; Riley U; Evans C; Newland A; Treleaven J; Singhal S
Bone Marrow Transplant; 1997 Jul; 20(1):39-43. PubMed ID: 9232254
[TBL] [Abstract][Full Text] [Related]
11. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
[TBL] [Abstract][Full Text] [Related]
12. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
Kern W; Behre G; Rudolf T; Kerkhoff A; Grote-Metke A; Eimermacher H; Kubica U; Wörmann B; Büchner T; Hiddemann W
Cancer; 1998 Jul; 83(2):291-301. PubMed ID: 9669812
[TBL] [Abstract][Full Text] [Related]
13. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients.
Nucci M; Biasoli I; Akiti T; Silveira F; Solza C; Barreiros G; Spector N; Derossi A; Pulcheri W
Clin Infect Dis; 2000 Feb; 30(2):300-5. PubMed ID: 10671332
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies].
Zhu Y; Chen SP; Shu YG; Xu YJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):89-92. PubMed ID: 18245913
[TBL] [Abstract][Full Text] [Related]
17. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases.
Reichenberger F; Habicht J; Kaim A; Dalquen P; Bernet F; Schläpfer R; Stulz P; Perruchoud AP; Tichelli A; Gratwohl A; Tamm M
Am J Respir Crit Care Med; 1998 Sep; 158(3):885-90. PubMed ID: 9731021
[TBL] [Abstract][Full Text] [Related]
18. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
[TBL] [Abstract][Full Text] [Related]
19. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
[TBL] [Abstract][Full Text] [Related]
20. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
